Rocket


Overview
Financials
News + Filings
Key Docs
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Director comp.
Credit agrmnt [a]
Director departure

New Amethyst Corp. (EVHC) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
10/22/2018 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
10/11/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/11/2018 8-K Quarterly results
09/11/2018 8-K Submission of Matters to a Vote of Security Holders, Other Events
09/10/2018 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 5.9% stake in Envision Healthcare Corp
09/06/2018 8-K Other Events
09/06/2018 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/29/2018 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/13/2018 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
08/06/2018 10-Q Quarterly Report for the period ended June 30, 2018
08/06/2018 8-K Quarterly results
Docs: "ENVISION HEALTHCARE REPORTS SOLID RESULTS FOR 2018 SECOND QUARTER"
07/25/2018 8-K Other Events
07/25/2018 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/20/2018 8-K Other Events
07/20/2018 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/09/2018 PREM14A Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
06/26/2018 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
06/13/2018 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, by and among Enterprise Parent Holdings Inc., Enterprise Merger Sub Inc. and Envision Healthcare Corporation."
06/13/2018 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
06/12/2018 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
06/11/2018 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
06/11/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "Envision Healthcare to be Acquired by KKR for $46.00 Per Share in All-Cash Transaction"
06/11/2018 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/10/2018 10-Q Quarterly Report for the period ended March 31, 2018
05/07/2018 8-K Quarterly results
Docs: "ENVISION HEALTHCARE REPORTS SOLID RESULTS FOR 2018 FIRST QUARTER"
04/30/2018 10-K/A Annual Report for the period ended December 31, 2017 [amend]
03/19/2018 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Departure of Directors or Cer...
Docs: "Amendment No. 1 to Stock Purchase Agreement, by and among Air Medical Group Holdings, Inc., Emergency Medical Services LP Corporation, AMR Holdco, Inc. and, for certain purposes of the Agreement, Envision Healthcare Corporation"
03/12/2018 SC 13G/A VANGUARD GROUP INC reports a 10% stake in Envision Healthcare Corp
02/28/2018 10-K Annual Report for the period ended December 31, 2017
02/27/2018 8-K Quarterly results
Docs: "ENVISION HEALTHCARE REPORTS 2017 FOURTH QUARTER FINANCIAL RESULTS INTRODUCES 2018 FINANCIAL GUIDANCE"
02/26/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Third Amended and Restated By-laws of Envision Healthcare Corporation (as of February 21, 2018)"
02/14/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2018 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy